Mankind Pharma Limited (NSE:MANKIND)
India · Delayed Price · Currency is INR 1,927.40
-72.60 (-3.63%)
At close: Mar 23, 2026
Mankind Pharma Market Cap
Mankind Pharma has a market cap or net worth of 795.69 billion as of March 23, 2026. Its market cap has decreased by -15.81% in one year.
Market Cap
795.69B
Enterprise Value
846.81B
Revenue
139.14B
Ranking
n/a
PE Ratio
44.61
Stock Price
1,927.40
Market Cap Chart
Since May 9, 2023, Mankind Pharma's market cap has increased from 569.76B to 795.69B, an increase of 39.65%. That is a compound annual growth rate of 12.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 825.66B | -8.94% |
| Dec 31, 2025 | 906.73B | -23.70% |
| Dec 31, 2024 | 1.19T | 49.64% |
| Dec 29, 2023 | 794.17B | 39.39% |
| May 9, 2023 | 569.76B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 1.62T |
| Cipla | 1.01T |
| Zydus Lifesciences | 896.05B |
| Aurobindo Pharma | 750.05B |
| Alkem Laboratories | 628.61B |
| Glenmark Pharmaceuticals | 615.23B |
| Laurus Labs | 532.95B |
| Ipca Laboratories | 391.95B |